secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2026-08-04T20:03:16+00:00
Accession:  0000318154-26-000124
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen Q2 2026 revenue up 10% to $10.1B; GAAP EPS $4.37 (+65%), non-GAAP EPS $6.29 (+4%)
--------------------------------------------------------------------------------

- Total revenues $10.1B (+10% YoY); product sales +9% driven by volume growth.
- GAAP EPS $4.37 (+65% from $2.65); non-GAAP EPS $6.29 (+4% from $6.02).
- GAAP operating margin 36.8% (+6.5pp); non-GAAP operating margin 48.4% (-0.5pp).
- Free cash flow $3.5B vs $1.9B in Q2 2025, helped by final repatriation tax payment timing.
- Six key growth drivers +26% YoY, ~70% of product sales; 22 products double-digit growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000031815426000124/0000318154-26-000124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000031815426000124/amgn-20260804.htm
  HTML page:      https://secwatch.observer/filing/0000318154-26-000124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer